Facilitation and inhibition of b16 melanoma by BCG in vivo and by lymphoid cells from bcg-treated mice in vitro.
D000818:Animals; D000937:Antigen-Antibody Reactions; D001500:BCG Vaccine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002455:Cell Division; D002478:Cells, Cultured; D003601:Cytotoxicity Tests, Immunologic; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D007111:Immunity, Cellular; D008198:Lymph Nodes / Q000473:pathology; D008545:Melanoma / Q000628:therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D013268:Stimulation, Chemical
D001500:BCG Vaccine